Pre-Made Somatropin Biosimilar, Recombinant Protein targeting GHR: Recombinant therapeutic protein targeting GHBP/GHIP for drug discovery and mechanism of action (MOA) research

Pre-Made Somatropin Biosimilar, Recombinant Protein targeting GHR: Recombinant therapeutic protein targeting GHBP/GHIP is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 5 years.

Somatotropin is a recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-995-1mg	1mg	3090
GMP-Bios-INN-995-10mg	10mg	Inquiry
GMP-Bios-INN-995-100mg	100mg	Inquiry
GMP-Bios-INN-995-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Somatropin Biosimilar, Recombinant Protein targeting GHR: Recombinant therapeutic protein targeting GHBP/GHIP
INN Name	Somatropin
Target	GHR
Format	Recombinant Protein
Derivation	human
Species Reactivity	human
CH1 Isotype	GH1 (growth hormone 1, somatotropin, GH, GH-N, GHN, hGH- N, pituitary growth hormone)
VD LC	GH1 (growth hormone 1, somatotropin, GH, GH-N, GHN, hGH- N, pituitary growth hormone)
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Genentech Inc. (S. San Francisco CA USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0